M

MITech Co Ltd
KOSDAQ:179290

Watchlist Manager
MITech Co Ltd
KOSDAQ:179290
Watchlist
Price: 7 990 KRW -1.36% Market Closed
Market Cap: 258.6B KRW
Have any thoughts about
MITech Co Ltd?
Write Note
MITech Co Ltd
/
Income Statement
/
Cost of Revenue

MITech Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MITech Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
MITech Co Ltd
KOSDAQ:179290
Cost of Revenue
-₩21.1B
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Dentium Co Ltd
KRX:145720
Cost of Revenue
-₩134.7B
CAGR 3-Years
-12%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
B
Biodyne Co Ltd
KOSDAQ:314930
Cost of Revenue
-₩3.4B
CAGR 3-Years
-2%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Cost of Revenue
-₩50.7B
CAGR 3-Years
-64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Cost of Revenue
-₩44.3B
CAGR 3-Years
-28%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
L
Lutronic Corp
KOSDAQ:085370
Cost of Revenue
-₩96.6B
CAGR 3-Years
-23%
CAGR 5-Years
-17%
CAGR 10-Years
-14%
No Stocks Found

MITech Co Ltd
Glance View

Market Cap
258.6B KRW
Industry
Health Care

M.I.Tech Co., Ltd. develops and manufactures non-vascular stent system. The company is headquartered in Pyeongtaek, Gyeonggi-Do and currently employs 157 full-time employees. The company went IPO on 2018-11-29. is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Company’s stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The firm distributes its products within the domestic market and to overseas markets.

Intrinsic Value
12 159.45 KRW
Undervaluation 34%
Intrinsic Value
Price
M
What is Intrinsic Value?

See Also

What is MITech Co Ltd's Cost of Revenue?
Cost of Revenue
-21.1B KRW

Based on the financial report for Dec 31, 2023, MITech Co Ltd's Cost of Revenue amounts to -21.1B KRW.

What is MITech Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-7%

Over the last year, the Cost of Revenue growth was 6%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.